0001062993-22-015670.txt : 20220630 0001062993-22-015670.hdr.sgml : 20220630 20220630160528 ACCESSION NUMBER: 0001062993-22-015670 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220607 FILED AS OF DATE: 20220630 DATE AS OF CHANGE: 20220630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dykan Jeff CENTRAL INDEX KEY: 0001661229 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36612 FILM NUMBER: 221058064 MAIL ADDRESS: STREET 1: KOCHAV YOKNEAM BUILDING, FLOOR 6 STREET 2: P.O. BOX 161 CITY: YOKNEAM ILIT STATE: L3 ZIP: 20692 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ReWalk Robotics Ltd. CENTRAL INDEX KEY: 0001607962 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 HATNUFA ST. STREET 2: FLOOR 6 CITY: YOKNEAM ILIT STATE: L3 ZIP: 2069203 BUSINESS PHONE: 97249590123 MAIL ADDRESS: STREET 1: 3 HATNUFA ST. STREET 2: FLOOR 6 CITY: YOKNEAM ILIT STATE: L3 ZIP: 2069203 FORMER COMPANY: FORMER CONFORMED NAME: Argo Medical Technologies Ltd. DATE OF NAME CHANGE: 20140513 4/A 1 form4a.xml AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4/A 2022-06-07 2022-06-09 0001607962 ReWalk Robotics Ltd. RWLK 0001661229 Dykan Jeff C/O REWALK ROBOTICS LTD. 3 HATNUFA ST., P.O. BOX 161 YOKNEAM ILIT L3 20692203 1 0 0 0 Ordinary Shares, par value NIS 0.25 per share 2022-06-07 4 P 0 15000 1 A 32162 D Ordinary Shares, par value NIS 0.25 per share 2022-06-08 4 P 0 10000 1.04 A 42162 D Ordinary Shares, par value NIS 0.25 per share 55874 I By Partnership This amendment is being filed to correct the number of shares directly and indirectly held by the reporting person. On July 7, 2020, the reporting person reported the acquisition of 10,948 Ordinary Shares underlying restricted stock units, which were granted to the reporting person on July 2, 2020 pursuant to the issuer's equity compensation plan. Such Ordinary Shares should have been reported as directly held, but due to an administrative error, such shares were mistakenly reported as indirectly held. See also footnote 6. Represents Ordinary Shares purchased in the open market on June 7, 2022. The range in prices for the transaction reported on this line was $1.00 to $1.01. The average weighted price was $1.00. The reporting person will provide, upon request by the Securities and Exchange Commission ("SEC"), the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range. Represents Ordinary Shares purchased in the open market on June 8, 2022. The range in prices for the transaction reported on this line was $1.03 to $1.04. The average weighted price was $1.04. The reporting person will provide, upon request by the SEC, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range. Based on filings made with the SEC, consists of 40,707 Ordinary Shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 Ordinary Shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 55,874 shares of the Company. /s/ Jeff Dykan 2022-06-30